510(k) · Cleared
ClearedPowder Free Nitrile Examination Gloves, Blue
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Syntex Healthcare Products Co., Ltd. · LZA Polymer Patient Examination Glove
Cleared on Oct 4, 2010 as substantially equivalent to K093726 (Medline Industries, Inc., 2010) after a 69-day review. Its family tree reaches back 1 generation to 2010. 1 later device descends from it.
- Decided
- Oct 4, 2010
- Review
- 69 days
- Class
- Class I
- Product code
- LZA
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K093726 (2010). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK093726 Mediguard Nitrile Examination Glove- Blue (Tested for Use with…Medline Industries, Inc. · 2010
- This deviceK102096 Powder Free Nitrile Examination Gloves, BlueSyntex Healthcare Products Co., Ltd. · 2010
- Descendant · cites it directly · 0 of its ownK140816 Powder Free Nitrile Examination Glove, Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2014
Most influential descendants
Showing 1 of 1 · See all- K140816Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue)Better Care Plastic Technology Co., Ltd. · 2014 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K093726 | Mediguard Nitrile Examination Glove- Blue (Tested for Use with Chemotherapy… | Medline Industries, Inc. | 2010 | — |
| 0 (this device) | K102096 | Powder Free Nitrile Examination Gloves, Blue | Syntex Healthcare Products Co., Ltd. | 2010 | — |
| +1 | K140816 | Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs… | Better Care Plastic Technology Co., Ltd. | 2014 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2014 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LZA device
- #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K093726 | Mediguard Nitrile Examination Glove- Blue (Tested for Use with Chemotherapy Drugs)Summary page 1…lue) 3. Predicate Device Information: Medline Industries Incorporated Mediguard Powder Free Nitrile Examination Glove (Blue)- Tested for use with Chemotherapy (K093726) 4. Device Description: Classified by FDA's General and Plastic Surgery Device panel as Class I, 21 CFR 880.6250, Polymer P… | 2010 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K140816 | Powder Free Nitrile Examination Glove, Tested for Use with Chemotherapy Drugs (Blue) | 2014 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- Of its descendants, K140816 (Better Care Plastic Technology Co., Ltd., 2014) has gone furthest, with 0 descendants of its own.
How does its category compare?
All LZA devicesLZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · LZA
24in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LZA
110in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LZA
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LZA
73in 2025
MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 21 | 95 | 0 | 7 |
| 2008 | 18 | 97 | 0 | 2 |
| 2009 | 28 | 112 | 0 | 12 |
| 2010 | 31 | 97 | 0 | 12 |
| 2011 | 26 | 122 | 0 | 9 |
| 2012 | 33 | 110 | 0 | 11 |
| 2013 | 20 | 130 | 0 | 10 |
| 2014 | 27 | 197 | 0 | 8 |
| 2015 | 20 | 112 | 1 | 12 |
| 2016 | 30 | 171 | 1 | 25 |
| 2017 | 44 | 124 | 0 | 4 |
| 2018 | 22 | 178 | 0 | 3 |
| 2019 | 25 | 212 | 0 | 21 |
| 2020 | 30 | 101 | 0 | 4 |
| 2021 | 139 | 111 | 0 | 20 |
| 2022 | 146 | 111 | 0 | 19 |
| 2023 | 62 | 92 | 0 | 24 |
| 2024 | 30 | 89 | 0 | 76 |
| 2025 | 24 | 110 | 0 | 73 |
| 2026 | 15 | 103 | 3 | — |
What is it indicated for?
A patient examination glove is disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. The tested chemotherapy drugs and their breakthrough detection times are as follows: Chemotherapy Drug Average BDT Fluorouracil >240 min. Etoposide (Toposar) >240 min., Cyclophosphamide (Cytoxan) >240 min. Carmustine 2.03 min. Thiotepa 25.23 min. Paclitaxel (Taxol) >240 min.…
Read the full statement (91 words)
A patient examination glove is disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
The tested chemotherapy drugs and their breakthrough detection times are as follows:
Chemotherapy Drug Average BDT
Fluorouracil >240 min.
Etoposide (Toposar) >240 min.,
Cyclophosphamide (Cytoxan) >240 min.
Carmustine 2.03 min.
Thiotepa 25.23 min.
Paclitaxel (Taxol) >240 min.
Doxorubicin Hydrochloride >240 min.
Dacarbazine (DTIC) >240 min.
Cisplatin >240 min.
Please note that Carmustine and Thiotepa have extremely low permeation times of less than 30 minutes.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K102096 · printed Nov 6, 2026
Cite this page
510(k) Report. “K102096: Powder Free Nitrile Examination Gloves, Blue.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K102096
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026